10 hrs ago
OncoGenex Announces Cedar Clinical Trial Evaluating Apatorsen...
Apatorsen is a once-weekly intravenous experimental drug that is designed to inhibit production of heat shock protein 27 to disable cancer cells' defenses and overcome treatment resistance .
Oncolytics Biotech Inc. Announces Completion of Patient Enrollment in ...
The principal investigator is Tanios Bekaii-Saab, MD, associate professor and gastrointestinal oncology section chief at The Hospital and Richard J. Solove Research Institute .
OncoGenex Announces Cedar Clinical Trial Evaluating Apatorsen in...
ORCAa program includes seven Phase 2 trials in tumor types where patient need is acute, including bladder, lung, pancreas and prostate cancers /CNW/ - OncoGenex Pharmaceuticals, Inc. today announced initiation of the Cedara clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating apatorsen in previously untreated ... (more)
Effectiveness of carboplatin and paclitaxel as first- and second-line ...
Patients with metastatic melanoma have a very unfavorable prognosis with few therapeutic options.
Combination of paclitaxel and carboplatin as second-line therapy for...
Patients with metastatic melanoma have very few therapy options. Based on reports of responses to paclitaxel and carboplatin , 31 patients with MM were treated with PC.
Applied Clinical Trials
AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib...
Specifically, the combination of veliparib, carboplatin and paclitaxel will be compared to treatment with carboplatin, paclitaxel and placebo in patients with human epidermal growth factor receptor 2- negative metastatic or locally-advanced breast cancer, containing BRCA1 and/or BRCA2 gene mutations.
International Business Times
Rodon Biologics Ties a Knot With Celllmid as 'Manufacturing Partner'
In a recent press release, Cellmid Ltd. has announced Rodon Biologics will be Cellmid's manufacturing partner for its latest "antibody" project.
First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.